MTDH-SND1 disruption sensitizes ovarian cancer to ferroptosis and PARP inhibition
Parisa Esmaeili, Ahmad Nasimian, Elsa Ernestal, Elna Persson, Bianca Bochis, Yuan Li, Måns Zamore, Anna Sandström Gerdtsson, Julhash Uddin Kazi, Fredrik Levander
This study shows that disrupting the MTDH-SND1 complex in BRCA-deficient ovarian cancer increases sensitivity to ferroptosis and PARP inhibition, with potential immune system benefits.
bioRxiv · May 20, 2026 · PreprintCancer Biology